CROMWELL, Conn. & GROTON, Conn.--(BUSINESS WIRE)--Biological Industries USA (“BI USA”), the North American division of Biological Industries, a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, stem cell research, and custom media manufacturing services, announces a major sponsorship of CURE Innovation Commons (“The Commons”), a new science and technology incubator in Groton, Connecticut. The sponsorship includes training, substantial product discounts and stem cell research grants for residents of The Commons throughout 2017.
“We are delighted to sponsor CURE Innovation Commons,” commented Tanya Potcova, CEO of BI USA. “Having opened our doors in Connecticut just last year, we see so much potential for research and collaboration in Connecticut. This particularly includes New London County, with its educated workforce, proximity to both Boston and New York City, and excellent infrastructure. We want to do all we can to help nurture that potential and to help ensure that the Nutmeg State becomes a true science hub.”
CURE Innovation Commons boasts 22,000 square feet of commercial-grade laboratory, office and coworking spaces as well as meeting and event facilities, complemented by modern technology infrastructure.
BI USA will kick off their sponsorship on November 17 during the second “Thirsty Thursday at The Commons,” an informal social gathering for the Connecticut entreprenures and industry professionals, at The Commons at 93 Shennacossett Road in Groton. The science and technology community are invited to visit from 4:30-6:30pm to sample the complimentary refreshments, including locally brewed beer, and enjoy a brief talk on the advantage of locating a life sciences startup in Connecticut by Peter Mousseau, founder of Rainbow Scientific in Windsor and board member of BI USA. In support of the Commons’ sponsorship of the Groton Food Locker Holiday Food Basket Program, guests are encouraged to bring non-perishable food items to the event. Scientists, start-ups, and all others from across field are welcome and encouraged to attend.
“We are very pleased to enter this sponsorship agreement with BI USA,” said Susan Froshauer, Ph.D., President of The Commons, and President and CEO of CURE (Connecticut United for Research Excellence). “We see it as an ideal partnership in which the local division of a major international life sciences company decides to invest in nurturing industry right in its own backyard. We thank Tanya and the team at BI USA and we look forward to working with them, toward making Connecticut a true leader in the life sciences.”
About Biological Industries
Biological Industries (BI) develops, manufactures, and supplies life science products to universities, government research, healthcare institutions, and the biopharmaceutical industry. For over 30 years, BI has been working alongside some of the world’s leading academic researchers and institutes in the development of cell culture media, stem cell reagents, and molecular biology tools. BI also offers custom media development and manufacturing services through its ISO 13485:2003 certified cGMP facilities. BI currently supplies products to researchers and clinicians in over 40 countries with products currently in clinical trials. BI is leveraging their industry-leading experience in cell culture media and pluripotent stem cell technology to help facilitate breakthroughs in stem cell research worldwide. BI is committed to a Culture of Excellence by providing the highest quality reagents and cost-effective, innovative products and services tailored to a customer’s specific needs. Biological Industries USA (BI USA) is the North American division of BI.
To receive ongoing BI communications, please join our email list or connect with the company on LinkedIn, Twitter, and Facebook.
About CURE Innovation Commons
CURE Innovation Commons is a new science and technology incubator in Southeastern Connecticut for entrepreneurs, scientists and companies to develop their ideas and build their businesses in a vibrant and collaborative community. Occupying approximately 22,000 square feet, the CURE Innovation Commons is leasing fully permitted, independent and shared laboratories, offices, co-working spaces, and a large meeting and event area. More information is available at www.curecommons.org and via LinkedIn, Twitter and Facebook.